Oragenics, Inc. (OGEN)
NYSEAMERICAN: OGEN · Real-Time Price · USD
0.4990
-0.0108 (-2.12%)
At close: Sep 1, 2026, 4:00 PM EDT
0.5100
+0.0110 (2.20%)
Pre-market: Sep 2, 2026, 6:04 AM EDT

Oragenics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
---0.040.130.09
Revenue Growth
----71.37%51.20%-
Gross Profit
-3.42-2.39-4.11-15.45-9.94-10.5
Operating Income
-10.47-9.36-10.56-20.9-14.42-15.77
Net Income
-10.08-9.84-10.57-20.66-14.29-15.71
Earnings Per Share
-2.51-4.56-47.88-275.48-213.36-242.59
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
3.868.40.863.4811.4427.27
Total Debt
-0.230.330.320.620.8
Net Cash (Debt)
3.868.170.543.1610.8226.47
Net Cash Growth
-1423.81%-83.03%-70.79%-59.12%58.11%
Net Cash Per Share
0.963.792.4342.16161.57408.69

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-10.21-9.25-8.6-7.29-15.23-13.47
Capital Expenditures
-----0.13-0.04
Free Cash Flow
-10.21-9.25-8.6-7.29-15.36-13.51
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Margin
----55519.89%-10964.61%-18131.88%
Pretax Margin
----54858.14%-10863.96%-18062.03%
Profit Margin
----54858.14%-10863.96%-18062.03%
FCF Margin
----19363.34%-11675.70%-15535.76%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
---383.9393.97596.78